Related references
Note: Only part of the references are listed.
Article
Medicine, General & Internal
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
Jennifer Hammond et al.
Summary: In high-risk, unvaccinated adults, treatment of Covid-19 with nirmatrelvir plus ritonavir can significantly reduce the risk of hospitalization and death, with good safety profile.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Letter
Medicine, General & Internal
Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic
Xinxin Zhang et al.
LANCET (2022)
Review
Infectious Diseases
COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients
Jennifer A. Belsky et al.
Summary: Severe COVID-19 caused by SARS-CoV-2 has a greater impact on immunocompromised patients such as cancer and solid organ transplant recipients, leading to higher comorbidities and poorer hospital outcomes. However, hematopoietic cell transplant recipients and pediatric cancer patients tend to have clinical presentations and outcomes similar to the general population.
JOURNAL OF INFECTION (2021)
Share Paper
